73 related articles for article (PubMed ID: 6548047)
1. [A case of chronic macrophageal leukemia].
Sinegubov KIu
Ter Arkh; 1984; 56(6):135-6. PubMed ID: 6548047
[No Abstract] [Full Text] [Related]
2. [Richter's syndrome (reversible after chemotherapy) during chronic lymphatic leukemia. Brief description of a case].
Cartei G; Fusaro A; Fornasiero A; Poletti A
G Clin Med; 1983; 64(7-8):252-6. PubMed ID: 6688996
[No Abstract] [Full Text] [Related]
3. [Treatment of acute nonlymphoblastic leukemia in childhood: results of protocol ANLL-827 and ANLL-861 studies. Children's Cancer and Leukemia Study Group].
Yanai M; Tsuji Y; Takeda T; Oka T; Yatabe M; Kikuta A; Kaneko Y; Sekine I; Matsushita T; Utsumi J
Rinsho Ketsueki; 1987 Oct; 28(10):1754-62. PubMed ID: 3330737
[No Abstract] [Full Text] [Related]
4. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
[TBL] [Abstract][Full Text] [Related]
5. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
[TBL] [Abstract][Full Text] [Related]
6. Prolymphocytic leukemia: diagnosis and treatment. A case report.
Akin C; Hansen P; Janckila A
J Ky Med Assoc; 1997 Nov; 95(11):465-7. PubMed ID: 9392933
[TBL] [Abstract][Full Text] [Related]
7. [Vincristine-induced recurrent laryngeal nerve paralysis].
Núñez E; Solano D; Arreita A; Franco-Vicario R; Miguel F
Rev Clin Esp; 1992 Mar; 190(4):214-5. PubMed ID: 1589626
[No Abstract] [Full Text] [Related]
8. A case of adult T-cell leukemia/lymphoma (ATL) with a survival of more than 13 years.
Bittencourt AL; Barbosa HS; Pimenta A; Farre L
Acta Oncol; 2008; 47(5):981-3. PubMed ID: 18568490
[No Abstract] [Full Text] [Related]
9. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
10. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
11. High-dose therapy for follicular lymphoma revisited: not if, but when?
Lister TA
J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
[No Abstract] [Full Text] [Related]
12. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
13. [Peripheral blood stem cell transplantation in adult acute lymphoblastic leukemia as postremission therapy].
Kuribara R; Muroi K; Yoshida M; Suzuki T; Izumi T; Hatake K; Amemiya Y; Miura Y
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1613-7. PubMed ID: 9725058
[No Abstract] [Full Text] [Related]
14. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
Binet JL
Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
[No Abstract] [Full Text] [Related]
15. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase II Study.
Miller TP; Jones SE; Rainey JM
Cancer Treat Rep; 1983; 67(7-8):739-40. PubMed ID: 6688200
[No Abstract] [Full Text] [Related]
17. A paraumbilical lymphomatous mass.
Burcheri S; Arcaini L
Eur J Haematol; 2006 Aug; 77(2):180. PubMed ID: 16856915
[No Abstract] [Full Text] [Related]
18. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
Paśnicki M
Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
[No Abstract] [Full Text] [Related]
19. [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
Rubio JA; Pulpón LA; Cavero MA; Oteo JF; Maicas C; Silva L; Serrano-Fiz S; Burgos R; Artaza M; Téllez G
Rev Esp Cardiol; 1994 Nov; 47(11):777-9. PubMed ID: 7800910
[TBL] [Abstract][Full Text] [Related]
20. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]